Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : PSP001
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : PSP001 is a novel, long acting and potent interferon lambda chimera injection for the treatment of chronic norovirus enteritis in hematopoietic and solid organ transplant recipients.
Product Name : PSP001
Product Type : Protein
Upfront Cash : Inapplicable
May 26, 2021
Lead Product(s) : PSP001
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
